Literature DB >> 35371932

Enhanced computed tomography imaging features predict tumor grade in pseudomyxoma peritonei.

Pengtao Sun1, Xinbao Li2, Lingling Wang3, Rengui Wang1, Xuechao Du4.   

Abstract

Background: Because few studies have focused on the correlation between computed tomography (CT) signs and tumor grade in pseudomyxoma peritonei (PMP), we evaluated predictive value of abdominal enhanced CT in identifying high- vs. low-grade cases.
Methods: In all, 75 patients diagnosed with PMP after surgery were consecutively recruited. The preoperative enhanced CT images were retrospectively analyzed for ascites, hepatic scalloping, omental and peritoneal lesion appearance, intralesional calcification and septa, and peripheral organ involvement. Logistic regression models were applied to analyze the relationship of CT signs with PMP grade. Receiver operating characteristic curves were generated to evaluate the potential utility of CT signs in detecting high-grade PMP.
Results: Massive ascites (P=0.017) and peritoneal solid nodules (P<0.001) were more common in high-grade cases. Multivariate logistic regression identified massive ascites [odds ratio (OR) =4.389, 95% confidence interval (CI): 1.210-15.921; P=0.025] and peritoneal solid nodules (OR =19.932, 95% CI: 3.560-111.596; P<0.001) as independent predictors of high-grade PMP. For the 55 patients with hepatic scalloping, the maximum thickness of mucin deposition at the hepatic scalloping wave in high-grade PMP was thinner than that in low-grade PMP (P=0.021). Thickness of mucin deposition at the hepatic scalloping wave (OR =0.346, 95% CI: 0.148-0.809; P=0.014) was an independent predictor of high-grade PMP, with a cutoff value of 18.6 mm. Cancer antigen 125 (CA125) combined with CT signs was significantly better at diagnosing high-grade PMP than was CA125 alone in both the overall patients [area under the ROC curve (AUC): 0.812 vs. 0.656; P=0.020] and those with hepatic scalloping (AUC: 0.859 vs. 0.600; P=0.007). Conclusions: The CT signs of high-grade PMP significantly differ from those of low-grade PMP, and thus combining CT signs with CA125 may be highly valuable for classifying PMP. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Computed tomography (CT); neoplasm grading; pseudomyxoma peritonei (PMP); scalloping

Year:  2022        PMID: 35371932      PMCID: PMC8923854          DOI: 10.21037/qims-21-976

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  30 in total

Review 1.  CT imaging of peritoneal carcinomatosis and its mimics.

Authors:  A D Diop; M Fontarensky; P-F Montoriol; D Da Ines
Journal:  Diagn Interv Imaging       Date:  2014-03-14       Impact factor: 4.026

2.  Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases.

Authors:  Norman J Carr; Jenny Finch; Ian Charles Ilesley; Kandiah Chandrakumaran; Faheez Mohamed; Alex Mirnezami; Tom Cecil; Brendan Moran
Journal:  J Clin Pathol       Date:  2012-06-20       Impact factor: 3.411

3.  Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.

Authors:  Robert F Bradley; John H Stewart; Gregory B Russell; Edward A Levine; Kim R Geisinger
Journal:  Am J Surg Pathol       Date:  2006-05       Impact factor: 6.394

4.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

Authors:  B M Ronnett; C M Zahn; R J Kurman; M E Kass; P H Sugarbaker; B M Shmookler
Journal:  Am J Surg Pathol       Date:  1995-12       Impact factor: 6.394

5.  Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Dario Baratti; Shigeki Kusamura; Massimo Milione; Federica Bruno; Marcello Guaglio; Marcello Deraco
Journal:  Ann Surg Oncol       Date:  2017-11-20       Impact factor: 5.344

6.  Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma.

Authors:  Frederic Mercier; Guedj Jeremie; Mohammad Alyami; Vaudoyer Delphine; Kepenekian Vahan; Rousset Pascal; Isaac Sylvie; Passot Guillaume; Glehen Olivier
Journal:  Surg Endosc       Date:  2019-12-02       Impact factor: 4.584

7.  Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival.

Authors:  Shreya Shetty; Bala Natarajan; Peter Thomas; Venkatesh Govindarajan; Poonam Sharma; Brian Loggie
Journal:  Am Surg       Date:  2013-11       Impact factor: 0.688

8.  Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Yoshimasa Gohda; Tsuyoshi Tajima; Tomomichi Kiyomatsu; Hideaki Yano
Journal:  Eur Radiol       Date:  2020-03-24       Impact factor: 5.315

9.  Intraperitoneal cytokine level in patients with peritoneal surface malignancies. A study of the RENAPE (French Network for Rare Peritoneal Malignancies).

Authors:  Virginie Vlaeminck-Guillem; Jacques Bienvenu; Sylvie Isaac; Blandine Grangier; François Golfier; Guillaume Passot; Naoual Bakrin; Claire Rodriguez-Lafrasse; François-Noël Gilly; Olivier Glehen
Journal:  Ann Surg Oncol       Date:  2013-03-22       Impact factor: 5.344

10.  Utility of noncontrast MRI in the detection and risk grading of gastrointestinal stromal tumor: a comparison with contrast-enhanced CT.

Authors:  Ziling Zhou; Jingyu Lu; John N Morelli; Daoyu Hu; Zhen Li; Peng Xiao; Xuemei Hu; Yaqi Shen
Journal:  Quant Imaging Med Surg       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.